Protecting axonal mitochondria prevents chemotherapy-driven neuropathy.

Abstract

Peripheral neuropathy is a poorly understood yet extraordinarily relevant obstacle to the effective implementation of cytotoxic chemotherapy in patients with cancer. Recent findings from Heles et al. demonstrate that safe neuroactive molecules that promote mitochondrial fitness in axons effectively prevent peripheral neuropathy in preclinical tumor models, thereby supporting clinical translation.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Keywords